Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EM 0477 / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Cerebrovascular accident
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: AMLODIPINE; PERINDOPRIL ARGININE
Diagnostic Lab Data:
CDC 'Split Type': NLPFIZER INC2021202398
Write-up: The person concerned has suffered a CVA and died on 29/01; This is a spontaneous report a contactable physician downloaded from the Regulatory Authority-WEB [regulatory authority NL-LRB-00446641] A 99-years-old female patient received first dose of bnt162b2 (COMIRNATY, Lot number: EM 0477), via an unspecified route of administration on 29Jan2021 at single dose for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included amlodipine, perindopril arginine. The patient experienced the person concerned has suffered a cva and died on 29/01 on 29Jan2021. The patient deceased within 1 day after vaccination. The patient died on 29Jan2021. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected.; Reporter''s Comments: BioNTech/Pfizer vaccin (Comirnaty) -Past drug therapy BioNTech/Pfizer vaccin (Comirnaty): no ---------- COVID19 -Previous COVID-19 infection: No Other -diagnostic procedures: no; Reported Cause(s) of Death: CVA
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166